United States · FDA National Drug Code directory
NYSTATIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 81033-015_50738a43-7297-270c-e063-6294a90af2cc
- Product NDC
- 81033-015
- Form
- SUSPENSION
- Composition / generic term
- NYSTATIN
- Labeler
- Kesin Pharma Corporation
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200814
- Source listing expiry
- 20271231
Source-listed ingredients
- NYSTATIN — 100000 U/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 473 mL in 1 BOTTLE (81033-015-16) · 81033-015-16
- 1 BOTTLE in 1 CARTON (81033-015-60) / 60 mL in 1 BOTTLE · 81033-015-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →